نتائج البحث 81-90 من 18938 لعملية البحث عن Two-phase
Randomized Phase II/III Trial of Adjuvant ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer.
Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...
... phase II dose (RP2D of APG2575 in combination ... Patients will be randomized 1:1 into the two arms. ... 2-6: 500 mg/m2). Patients randomized to B+R will ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...
In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...
Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The purpose of ...
... phase 2 dose (RP2D) of APG-2575. A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies. Rochester, Minn., Jacksonville ...
This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.